Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of
coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the …

We aerosolized severe acute respiratory syndrome coronavirus 2 and determined that its
dynamic aerosol efficiency surpassed those of severe acute respiratory syndrome coronavirus …

14. ABSTRACT What does it mean to describe an infection as airborne and what are the
clinical implacations? The concept of the air we breathe as a reservoir for disease-causing …

Point-of-care COVID-19 assays that are more sensitive than the current RT-PCR (reverse
transcription polymerase chain reaction) gold standard assay are needed to improve disease …

SARS-CoV-2 infection can cause fatal inflammatory lung pathology, including thrombosis
and increased pulmonary vascular permeability leading to edema and hemorrhage. In …

Plasma SARS-CoV-2 RNA may represent a viable diagnostic alternative to respiratory RNA
levels, which rapidly decline after infection. Quantitative PCR with reverse transcription (RT–…

… Roy CJ, Reed DS. Infectious disease aerobiology: miasma incarnate. Front Cell Infect
Microbiol 2012;2:163. … Verreault D, Killeen SZ, Redmann RK, Roy CJ. Susceptibility of …

COVID-19 transmits by droplets generated from surfaces of airway mucus during processes
of respiration within hosts infected by severe acute respiratory syndrome coronavirus 2 (…

SARS-CoV-2 infection is required for COVID-19, but many signs and symptoms of COVID-19
differ from common acute viral diseases. SARS-CoV-2 infection is necessary but not …

Tuberculosis (TB) is a global pandaemic, partially due to the failure of vaccination approaches.
Novel anti-TB vaccines are therefore urgently required. Here we show that aerosol …